铜绿假单胞菌临床分离株致病特征及Quorum Sensing系统调控机制研究
|
摘要
[目的]从临床角度出发，排除人为因素影响，研究临床野生铜绿假单胞菌致病能力，探讨密度感应系统(Quorum Sensing, QS)与铜绿假单胞菌致病性的关系，为QS系统群体控制理论提供新信息，为临床控制铜绿假单胞菌感染提供第一手资料，为临床控制铜绿假单胞菌感染寻找新的治疗策略。
[方法]以铜绿假单胞菌临床感染特征及对策为研究方向，以铜绿假单胞菌临床分离株为研究对象，分析铜绿假单胞菌临床感染分布特点、耐药规律；检测QS系统功能缺陷时铜绿假单胞菌毒力因子表达变化情况；检测QS系统编码基因突变特点，分析QS系统对毒力因子表达调控机制。
[结果]1、本研究的铜绿假单胞菌感染在呼吸道最为突出；在ICU最为多见；铜绿假单胞菌耐药问题严重，有多重耐药，与目前大多数研究结果基本一致。2、本研究检测84株铜绿假单胞菌临床分离株，95．34％的菌株QS系统功能正常，QS系统功能缺陷株检出率只有4．76％。3、QS系统功能缺陷株多种毒力因子表达均有不同程度的障碍，QS系统对铜绿假单胞菌各致病因子表达或严格控制，或部分调控。QS系统严格调控弹性蛋白酶分泌，QS系统是绿脓菌素分泌、生物被膜形成和泳动能力调控机制之一。4、在铜绿假单胞菌QS系统中，rh1系统参与了弹性蛋白酶表达、绿脓菌素分泌、生物被膜形成和泳动能力调控。5、临床分离铜绿假单胞菌QS系统功能缺陷株QS系统编码基因发生突变(包括基因缺失和或点突变)，许多突变位点相同。
[结论]1、铜绿假单胞菌临床分离株绝大多数QS系统功能正常，少数QS系统功能缺陷，QS系统功能缺陷株致病能力减弱，说明QS系统在铜绿假单胞菌临床感染的过程中发挥了重要作用，干扰铜绿假单胞菌OS系统可能是一种非常有希望的新治疗手段。2、铜绿假单胞菌QS系统功能缺陷株致病能力减弱，但QS系统功能缺陷并未导致铜绿假单胞菌致病能力完全丧失，干扰铜绿假单胞菌QS系统不能完全清除感染，细菌可利用自身及环境中的一切有利因素生存，控制铜绿假单胞菌感染可能需要多种手段联合使用。3、铜绿假单胞菌致病性强弱受包括QS系统在内的复杂网络调控，宿主个体差异、内环境、免疫功能状态等因素在铜绿假单胞菌建立感染过程中的作用不容忽视。4、铜绿假单胞菌QS系统编码基因存在突变高发区。
Objective This paper studied the pathogenic capabilities of clinical wild PA strains and probed the relationship between the QS system and the pathogenicity of PA from a clinical point of view. New information for group control theory of the QS system, first-hand material for clinical control of PA infection, toy and to new strategies for clinical control of PA infection are provided in this study.
Methods By using the characteristics and countermeasures of PA clinical infection as the research direction, and clinically isolated PA strains as the research objects, we,,analyzed the distribution characteristics and drug resistance of PA clinical infection, we also tested changes of PA virulence factors expression upon the QS system failure. The encoding gene mutation features of QS system and the regulation mechanisms of QS system to virulence factors were also investigated.
Results 1. The drug resistance and clinical distribution of PA in the Wuhan region are consistent with results reported by other researches.2. In 84 clinical isolated PA strains, most (95.34%) show normal QS system.. We have screened out four QS defective strains (4.76%).3. The expressions of various virulence factors of these defective strains are all defective to different extent, and QS system control strictly or partially the pathogenesis of PA.. Elastase secretion is strictly regulated by the QS system. Pyocyanine secretion, bacteria biofilm formation and swimming ability are regulated by QS system 4. RHL system plays an important role in the secretion of pyocyanine. Biofilm formation and swimming ability are also regulated by RHL system.5. PA QS system exists highly mutation-prone region. The coding genes of local PA QS system are not identical with those of wild standard strains.
Conclusion 1. The functions of QS system in most clinically isolated PA strains is normal, and it suggests that QS system plays an important role in the process of clinical PA infection. Interference with QS system could be a very promising new treatment, which deserves further study.2. The pathogenic ability of QS defective strains flaws, but they can still establish infections. The defection of QS system doesn not completely disable the pathogenesis. Interfering with PA QS system cannot completely remove bacterial infection, and the bacteria can survive through all the favorable elements, and to control PA infection may need to use a combination of all kinds of means.3.The strength of PA pathogenic ability is regulated by a complex network including the QS system. The effect of the individual differences in the host, internal environment factors, and the immune function cannot be ignored when PA establishes infections.4.The encode gene of QS system exits a highly mutational area.
[方法]以铜绿假单胞菌临床感染特征及对策为研究方向，以铜绿假单胞菌临床分离株为研究对象，分析铜绿假单胞菌临床感染分布特点、耐药规律；检测QS系统功能缺陷时铜绿假单胞菌毒力因子表达变化情况；检测QS系统编码基因突变特点，分析QS系统对毒力因子表达调控机制。
[结果]1、本研究的铜绿假单胞菌感染在呼吸道最为突出；在ICU最为多见；铜绿假单胞菌耐药问题严重，有多重耐药，与目前大多数研究结果基本一致。2、本研究检测84株铜绿假单胞菌临床分离株，95．34％的菌株QS系统功能正常，QS系统功能缺陷株检出率只有4．76％。3、QS系统功能缺陷株多种毒力因子表达均有不同程度的障碍，QS系统对铜绿假单胞菌各致病因子表达或严格控制，或部分调控。QS系统严格调控弹性蛋白酶分泌，QS系统是绿脓菌素分泌、生物被膜形成和泳动能力调控机制之一。4、在铜绿假单胞菌QS系统中，rh1系统参与了弹性蛋白酶表达、绿脓菌素分泌、生物被膜形成和泳动能力调控。5、临床分离铜绿假单胞菌QS系统功能缺陷株QS系统编码基因发生突变(包括基因缺失和或点突变)，许多突变位点相同。
[结论]1、铜绿假单胞菌临床分离株绝大多数QS系统功能正常，少数QS系统功能缺陷，QS系统功能缺陷株致病能力减弱，说明QS系统在铜绿假单胞菌临床感染的过程中发挥了重要作用，干扰铜绿假单胞菌OS系统可能是一种非常有希望的新治疗手段。2、铜绿假单胞菌QS系统功能缺陷株致病能力减弱，但QS系统功能缺陷并未导致铜绿假单胞菌致病能力完全丧失，干扰铜绿假单胞菌QS系统不能完全清除感染，细菌可利用自身及环境中的一切有利因素生存，控制铜绿假单胞菌感染可能需要多种手段联合使用。3、铜绿假单胞菌致病性强弱受包括QS系统在内的复杂网络调控，宿主个体差异、内环境、免疫功能状态等因素在铜绿假单胞菌建立感染过程中的作用不容忽视。4、铜绿假单胞菌QS系统编码基因存在突变高发区。
Objective This paper studied the pathogenic capabilities of clinical wild PA strains and probed the relationship between the QS system and the pathogenicity of PA from a clinical point of view. New information for group control theory of the QS system, first-hand material for clinical control of PA infection, toy and to new strategies for clinical control of PA infection are provided in this study.
Methods By using the characteristics and countermeasures of PA clinical infection as the research direction, and clinically isolated PA strains as the research objects, we,,analyzed the distribution characteristics and drug resistance of PA clinical infection, we also tested changes of PA virulence factors expression upon the QS system failure. The encoding gene mutation features of QS system and the regulation mechanisms of QS system to virulence factors were also investigated.
Results 1. The drug resistance and clinical distribution of PA in the Wuhan region are consistent with results reported by other researches.2. In 84 clinical isolated PA strains, most (95.34%) show normal QS system.. We have screened out four QS defective strains (4.76%).3. The expressions of various virulence factors of these defective strains are all defective to different extent, and QS system control strictly or partially the pathogenesis of PA.. Elastase secretion is strictly regulated by the QS system. Pyocyanine secretion, bacteria biofilm formation and swimming ability are regulated by QS system 4. RHL system plays an important role in the secretion of pyocyanine. Biofilm formation and swimming ability are also regulated by RHL system.5. PA QS system exists highly mutation-prone region. The coding genes of local PA QS system are not identical with those of wild standard strains.
Conclusion 1. The functions of QS system in most clinically isolated PA strains is normal, and it suggests that QS system plays an important role in the process of clinical PA infection. Interference with QS system could be a very promising new treatment, which deserves further study.2. The pathogenic ability of QS defective strains flaws, but they can still establish infections. The defection of QS system doesn not completely disable the pathogenesis. Interfering with PA QS system cannot completely remove bacterial infection, and the bacteria can survive through all the favorable elements, and to control PA infection may need to use a combination of all kinds of means.3.The strength of PA pathogenic ability is regulated by a complex network including the QS system. The effect of the individual differences in the host, internal environment factors, and the immune function cannot be ignored when PA establishes infections.4.The encode gene of QS system exits a highly mutational area.
引文
[1]Bassetti M, Righi E, Viscoli C. Pseudomonas aeruginosa serious infections:mono or combination antimicrobial therapy?[J]. Curr Med Chem.2008,15(5):517-522.
[2]刘振声；金大棚；陈增辉．医院感染管理学[G]．北京：军事医学科学出版社，2000．
[3]Stover C K, Pham X Q, Erwin A L, et al. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen.[J]. Nature.2000,406(6799):959-964.
[4]Lyczak J B, Cannon C L, Pier G B. Establishment of Pseudomonas aeruginosa infection:lessons from a versatile opportunist.[J]. Microbes Infect.2000,2(9):1051-1060.
[5]Pier G. Pseudomonas aeruginosa:a key problem in cystic fibrosis[J]. ASM News.1998,64(6): 339-347.
[6]谢丽丽，熊盛道，刘谨，等．铜绿假单胞菌耐亚胺培南相关基因OprD2研究[J]．医药导报．2006，25(2)：102-104．
[7]陈民钧，王辉，中国医院内病原菌耐药监测网．中国重症监护病房革兰阴性菌耐药性连续7年监测研究[J]．中华医学杂志．2003，83(5)．
[8]曹彬，王辉，朱元珏，等．多药耐药铜绿假单胞菌院内感染危险因素及预后因素分析[J]．中华结核和呼吸杂志．2004，27(1)．
[9]叶惠芬，杨银梅，陈惠玲，等．2001年广州地区常见病原菌耐药性调查[J]．中国抗生素杂志．2002，27(10)．
[10]Cowell B A, Chen D Y, Frank D W, et al. ExoT of cytotoxic Pseudomonas aeruginosa prevents uptake by corneal epithelial cells.[J]. Infect Immun.2000,68(1):403-406.
[11]Murray S A, Snydman D R. Investigation of an epidemic of multi-drug resistant Pseudomonas aeruginosa.[J]. Infect Control.1982,3(6):456-460.
[12]Nakayama I, Yamaji E. [The recent trend of multi-drug resistant Pseudomonas aeruginosa in the field of surgery][J]. Nippon Rinsho.1991,49(10):2373-2380.
[13]Tomono K, Sawai T, Kohno S. [Multi-drug resistant Pseudomonas aeruginosa infection][J]. Ryoikibetsu Shokogun Shirizu.1999(23 Pt 1):198-201.
[14]Tomasoni D, Gattuso G, Chiarelli C, et al. [Epidemiologic surveillance of multi-drug resistant Pseudomonas aeruginosa in Mantova Hospital (Italy)][J]. Infez Med.2006,14(2):85-91.
[15]Anguige K, King J R, Ward J P. Modelling antibiotic-and anti-quorum sensing treatment of a spatially-structured Pseudomonas aeruginosa population.[J]. J Math Biol.2005,51(5):557-594.
[16]Bjarnsholt T, Jensen P O, Burmolle M, et al. Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent.[J]. Microbiology.2005,151(Pt2):373-383.
[17]Cao B, Wang H, Sun H, et al. Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections.[J]. J Hosp Infect.2004,57(2):112-118.
[18]Chapon-Herve V, Akrim M, Latifi A, et al. Regulation of the xcp secretion pathway by multiple quorum-sensing modulons in Pseudomonas aeruginosa.[J]. Mol Microbiol.1997,24(6):1169-1178.
[19]Chernukha M, Shaginian I A, Romanova I, et al. [The role of "quorum sensing" regulation system in symbiotic interaction of bacteria Burkholderia cepacia and Pseudomonas aeruginosa during mixed infection][J]. Zh Mikrobiol Epidemiol Immunobiol.2006(4):32-37.
[20]Falagas M E, Kopterides P. Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa:a systematic review of the literature.[J]. J Hosp Infect. 2006,64(1):7-15.
[21]Hasegawa M, Kobayashi I, Saika T, et al. [Development of multi-drug resistant mutants of clinical isolates of Pseudomonas aeruginosa after exposure to fluoroquinolone][J]. Kansenshogaku Zasshi. 1996,70(2):123-131.
[22]Hust'Avova H, Krcmery V, Kanik K, et al. Conjugation in lysogenic, multiple-drug resistant, nosocomial strains of Pseudomonas aeruginosa producing a hemolytic toxin.[J]. Zentralbl Bakteriol Orig A.1977,239(1):59-61.
[23]Girard G, Bloemberg G V. Central role of quorum sensing in regulating the production of pathogenicity factors in Pseudomonas aeruginosa.[J]. Future Microbiol.2008,3(1):97-106.
[24]Jayakumar S, Appalaraju B. Prevalence of multi and pan drug resistant Pseudomonas aeruginosa with respect to ESBL and MBL in a tertiary care hospital.[J]. Indian J Pathol Microbiol.2007,
50(4):922-925.
[25]王辉，陈民钧，中国医院内病原菌耐药监测网．1994-2001年中国重症监护病房非发酵糖细菌的耐药变迁[J]．中华医学杂志．2003，83(5)．
[26]刘蓉，周黎明，王浴生．铜绿假单胞菌对β-内酰胺类抗生素耐药机制[J]．四川生理科学杂志．2004，26(4)．
[27]植志全，何志恒，江鹏，等．多重耐药绿脓假单胞菌β内酰胺类氨基糖苷类耐药相关基因研究[J]．中华检验医学杂志．2005，28(11)：1211-1214．
[28]张春平，龙腾镶，黄文方，等．铜绿假单胞菌产金属β-内酰胺酶的研究进展[J]．国际检验医学杂志．2006，27(3)：252-254．
[29]胡锡浩，许小敏，虞江声，等．耐亚胺培南铜绿假单胞菌产金属β-内酰胺酶的检测及其耐药性分析[J]．现代实用医学．2006，18(5)：306-308．
[30]王佩芬，张娟，黄源春．耐亚胺培南铜绿假单胞菌产金属β-内酰胺酶的研究[J]．国际检验医学杂志．2006，27(5)：405-406．
[31]Mugnier P, Dubrous P, Casin I, et al. A TEM-derived extended-spectrum beta-lactamase in Pseudomonas aeruginosa.[J]. Antimicrob Agents Chemother.1996,40(11):2488-2493.
[32]Lepper P M, Grusa E, Reichl H, et al. Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa.[J]. Antimicrob Agents Chemother.2002,46(9):2920-2925.
[33]陈瑞，唐英春，朱家馨，等．铜绿假单胞菌对碳青霉烯类抗生素的耐药机制——耐药株外膜蛋白OprD2缺失[J]．中国抗感染化疗杂志．2001，1(4)．
[34]蒋伟，常东，黄志红，等．多重耐药铜绿假单胞菌氨基糖苷类修饰酶基因及qacE △ 1基因检测研究[J]．解放军医学杂志．2006，3l(1)．
[35]Mouneimne H, Robert J, Jarlier V, et al. Type Ⅱ topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa.[J]. Antimicrob Agents Chemother.1999,43(1):62-66.
[36]Akasaka T, Tanaka M, Yamaguchi A, et al. Type Ⅱ topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance.[J]. Antimicrob Agents Chemother.2001,45(8):2263-2268.
[37]Brown M H, Paulsen I T, Skurray R A. The multidrug efflux protein NorM is a prototype of a new family of transporters. [J]. Mol Microbiol.1999,31(1):394-395.
[38]Nickel J C, Ruseska I, Wright J B, et al. Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material.[J]. Antimicrob Agents Chemother.1985,27(4): 619-624.
[39]Lawrence D. Clues to mechanism of Pseudomonas resistance in cystic fibrosis.[J]. Lancet.2002, 359(9315):1410.
[40]Patel R. Biofilms and antimicrobial resistance.[J]. Clin Orthop Relat Res.2005(437):41-47.
[41]Stewart P S, Costerton J W. Antibiotic resistance of bacteria in biofilms.[J]. Lancet.2001, 358(9276):135-138.
[42]Sedlacek M J, Walker C. Antibiotic resistance in an in vitro subgingival biofilm model.[J]. Oral Microbiol Immunol.2007,22(5):333-339.
[43]Lee H W, Koh Y M, Kim J, et al. Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces.[J]. Clin Microbiol Infect.2008, 14(1):49-54.
[44]张海平，胡必杰，李华茵，等.头孢他啶对早期和成熟期绿脓假单胞菌生物膜菌作用的差别[J].中华检验医学杂志.2003，26(6):349-351.
[45]孙景勇，倪语星.住院病人中分离的革兰阴性杆菌的分布与耐药特征[J].中国抗感染化疗杂志.2002，2(3).
[1]Smith K M, Bu Y, Suga H. Induction and inhibition of Pseudomonas aeruginosa quorum sensing by synthetic autoinducer analogs.[J]. Chem Biol.2003,10(1):81-89.
[2]Schaber J A, Carty N L, Mcdonald N A, et al. Analysis of quorum sensing-deficient clinical isolates of Pseudomonas aeruginosa.[J]. J Med Microbiol.2004,53(Pt 9):841-853.
[3]Essar D W, Eberly L, Hadero A, et al. Identification and characterization of genes for a second anthranilate synthase in Pseudomonas aeruginosa:interchangeability of the two anthranilate synthases and evolutionary implications.[J]. J Bacteriol.1990,172(2):884-900.
[4]Deziel E, Comeau Y, Villemur R. Initiation of biofilm formation by Pseudomonas aeruginosa 57RP correlates with emergence of hyperpiliated and highly adherent phenotypic variants deficient in swimming, swarming, and twitching motilities.[J]. J Bacteriol.2001,183(4):1195-1204.
[5]Bassetti M, Righi E, Viscoli C. Pseudomonas aeruginosa serious infections:mono or combination antimicrobial therapy?[J]. Curr Med Chem.2008,15(5):517-522.
[6]刘振声;金大棚;陈增辉.医院感染管理学[G].北京：军事医学科学出版社，2000.
[7]Davies D G, Parsek M R, Pearson J P, et al. The involvement of cell-to-cell signals in the development of a bacterial biofilm.[J]. Science.1998,280(5361):295-298.
[8]De Kievit T R, Iglewski B H. Bacterial quorum sensing in pathogenic relationships.[J]. Infect Immun.2000,68(9):4839-4849.
[9]Smith R S, Iglewski B H. P. aeruginosa quorum-sensing systems and virulence.[J]. Curr Opin Microbiol.2003,6(1):56-60.
[10]Cegelski L, Marshall G R, Eldridge G R, et al. The biology and future prospects of antivirulence therapies.[J]. Nat Rev Microbiol.2008,6(1):17-27.
[11]Rumbaugh K P, Diggle S P, Watters C M, et al. Quorum sensing and the social evolution of bacterial virulence.[J]. Curr Biol.2009,19(4):341-345.
[12]Sperandio V, Torres A G, Jarvis B, et al. Bacteria-host communication:the language of hormones.[J]. Proc Natl Acad Sci U S A.2003,100(15):8951-8956.
[13]Keller L, Surette M G. Communication in bacteria:an ecological and evolutionary perspective.[J]. Nat Rev Microbiol.2006,4(4):249-258.
[14]Rumbaugh K P. Convergence of hormones and autoinducers at the host/pathogen interface. [J]. Anal Bioanal Chem.2007,387(2):425-435.
[15]Shiner E K, Rumbaugh K P, Williams S C. Inter-kingdom signaling:deciphering the language of acyl homoserine lactones.[J]. FEMS Microbiol Rev.2005,29(5):935-947.
[16]Hughes D T, Sperandio V. Inter-kingdom signalling:communication between bacteria and their hosts.[J]. Nat Rev Microbiol.2008,6(2):111-120.
[17]Sperandio V. Striking a balance:inter-kingdom cell-to-cell signaling, friendship or war?[J]. Trends Immunol.2004,25(10):505-507.
[18]Bratu S, Gupta J, Quale J. Expression of the las and rhl quorum-sensing systems in clinical isolates of Pseudomonas aeruginosa does not correlate with efflux pump expression or antimicrobial resistance.[J]. J Antimicrob Chemother.2006,58(6):1250-1253.
[19]Kumari A, Pasini P, Daunert S. Detection of bacterial quorum sensing N-acyl homoserine lactones in clinical samples.[J]. Anal Bioanal Chem.2008,391(5):1619-1627.
[20]Schaber J A, Carty N L, Mcdonald N A, et al. Analysis of quorum sensing-deficient clinical isolates of Pseudomonas aeruginosa. [J]. J Med Microbiol.2004,53(Pt 9):841-853.
[21]Bosgelmez-Tinaz G, Ulusoy S. Characterization of N-butanoyl-L-homoserine lactone (C4-HSL) deficient clinical isolates of Pseudomonas aeruginosa. [J]. Microb Pathog.2008,44(1):13-19.
[22]Bever R A, Iglewski B H. Molecular characterization and nucleotide sequence of the Pseudomonas aeruginosa elastase structural gene.[J]. J Bacteriol.1988,170(9):4309-4314.
[23]Ball G, Durand E, Lazdunski A, et al. A novel type II secretion system in Pseudomonas aeruginosa.[J]. Mol Microbiol.2002,43(2):475-485.
[24]Mciver K S, Olson J C, Ohman D E. Pseudomonas aeruginosa lasB 1 mutants produce an elastase, substituted at active-site His-223, that is defective in activity, processing, and secretion.[J]. J Bacteriol.1993,175(13):4008-4015.
[25]Yanagihara K, Tomono K, Kaneko Y, et al. Role of elastase in a mouse model of chronic
respiratory Pseudomonas aeruginosa infection that mimics diffuse panbronchiolitis.[J]. J Med Microbiol.2003,52(Pt 6):531-535.
[26]Heck L W, Morihara K, Mcrae W B, et al. Specific cleavage of human type Ⅲ and Ⅳ collagens by Pseudomonas aeruginosa elastase.[J]. Infect Immun.1986,51(1):115-118.
[27]Heck L W, Alarcon P G, Kulhavy R M, et al. Degradation of IgA proteins by Pseudomonas aeruginosa elastase.[J]. J Immunol.1990,144(6):2253-2257.
[28]Schmidtchen A, Holst E, Tapper H, et al. Elastase-producing Pseudomonas aeruginosa degrade plasma proteins and extracellular products of human skin and fibroblasts, and inhibit fibroblast growth.[J]. Microb Pathog.2003,34(1):47-55.
[29]Hamdaoui A, Wund-Bisseret F, Bieth J G. Fast solubilization of human lung elastin by Pseudomonas aeruginosa elastase.[J]. Am Rev Respir Dis.1987,135(4):860-863.
[30]Reimer A, Edvaller B, Johansson B. Concentrations of the Pseudomonas aeruginosa toxin pyocyanin in human ear secretions.[J]. Acta Otolaryngol Suppl.2000,543:86-88.
[31]Nadell C D, Xavier J B, Levin S A, et al. The evolution of quorum sensing in bacterial biofilms.[J]. PLoS Biol.2008,6(1):14.
[32]Parsek M R, Tolker-Nielsen T. Pattern formation in Pseudomonas aeruginosa biofilms.[J]. Curr Opin Microbiol.2008,11(6):560-566.
[33]Rodriguez-Martinez J M, Pascual A. [Activity of antimicrobial agents on bacterial biofilms][J]. Enferm Infecc Microbiol Clin.2008,26(2):107-114.
[34]Spormann A M. Physiology of microbes in biofilms.[J]. Curr Top Microbiol Immunol.2008,322: 17-36.
[35]Wagner V E, Iglewski B H. P. aeruginosa Biofilms in CF Infection.[J]. Clin Rev Allergy Immunol. 2008,35(3):124-134.
[36]Lee H W, Koh Y M, Kim J, et al. Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces.[J]. Clin Microbiol Infect.2008, 14(1):49-54.
[37]Sedlacek M J, Walker C. Antibiotic resistance in an in vitro subgingival biofilm model.[J]. Oral Microbiol Immunol.2007,22(5):333-339.
[38]Stewart P S, Costerton J W. Antibiotic resistance of bacteria in biofilms.[J]. Lancet.2001, 358(9276):135-138.
[39]Patel R. Biofilms and antimicrobial resistance.[J]. Clin Orthop Relat Res.2005(437):41-47.
[40]Lawrence D. Clues to mechanism of Pseudomonas resistance in cystic fibrosis.[J]. Lancet.2002, 359(9315):1410.
[1]Schaber J A, Carty N L, Mcdonald N A, et al. Analysis of quorum sensing-deficient clinical isolates of Pseudomonas aeruginosa.[J]. J Med Microbiol.2004,53(Pt 9):841-853.
[2]Smith R S, Iglewski B H. P. aeruginosa quorum-sensing systems and virulence.[J]. Curr Opin Microbiol.2003,6(1):56-60.
[3]Borriello G, Werner E, Roe F, et al. Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms.[J]. Antimicrob Agents Chemother.2004,48(7):2659-2664.
[4]Pearson J P, Feldman M, Iglewski B H, et al. Pseudomonas aeruginosa cell-to-cell signaling is required for virulence in a model of acute pulmonary infection.[J]. Infect Immun.2000,68(7): 4331-4334.
[5]De Kievit T R, Iglewski B H. Bacterial quorum sensing in pathogenic relationships.[J]. Infect Immun.2000,68(9):4839-4849.
[6]Bosgelmez-Tinaz G, Ulusoy S. Characterization of N-butanoyl-L-homoserine lactone (C4-HSL) deficient clinical isolates of Pseudomonas aeruginosa.[J]. Microb Pathog.2008,44(1):13-19.
[7]Lawrence D. Clues to mechanism of Pseudomonas resistance in cystic fibrosis.[J]. Lancet.2002, 359(9315):1410.
[8]Lee H W, Koh Y M, Kim J, et al. Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces.[J]. Clin Microbiol Infect.2008, 14(1):49-54.
[9]Patel R. Biofilms and antimicrobial resistance.[J]. Clin Orthop Relat Res.2005(437):41-47.
[10]Sedlacek M J, Walker C. Antibiotic resistance in an in vitro subgingival biofilm model.[J]. Oral Microbiol Immunol.2007,22(5):333-339.
[11]Stewart P S, Costerton J W. Antibiotic resistance of bacteria in biofilms.[J]. Lancet.2001, 358(9276):135-138.
[12]Borriello G, Werner E, Roe F, et al. Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms.[J]. Antimicrob Agents Chemother.2004,48(7):2659-2664.
[13]Smith R S, Iglewski B H. Pseudomonas aeruginosa quorum sensing as a potential antimicrobial target.[J]. J Clin Invest.2003,112(10):1460-1465.
[14]Rasmussen T B, Givskov M. Quorum-sensing inhibitors as anti-pathogenic drugs.[J]. Int J Med Microbiol.2006,296(2-3):149-161.
[15]Wagner V E, Bushnell D, Passador L, et al. Microarray analysis of Pseudomonas aeruginosa quorum-sensing regulons:effects of growth phase and environment.[J]. J Bacteriol.2003,185(7): 2080-2095.
[16]Schuster M, Lostroh C P, Ogi T, et al. Identification, timing, and signal specificity of Pseudomonas aeruginosa quorum-controlled genes:a transcriptome analysis.[J]. J Bacteriol.2003,185(7): 2066-2079.
[17]Hentzer M, Wu H, Andersen J B, et al. Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors.[J]. EMBO J.2003,22(15):3803-3815.
[18]Smith R S, Iglewski B H. P. aeruginosa quorum-sensing systems and virulence.[J]. Curr Opin Microbiol.2003,6(1):56-60.
[19]Willcox M D, Zhu H, Conibear T C, et al. Role of quorum sensing by Pseudomonas aeruginosa in microbial keratitis and cystic fibrosis.[J]. Microbiology.2008,154(Pt 8):2184-2194.
[20]Pearson J P, Pesci E C, Iglewski B H. Roles of Pseudomonas aeruginosa las and rhl quorum-sensing systems in control of elastase and rhamnolipid biosynthesis genes.[J]. J Bacteriol.1997,179(18): 5756-5767.
[21]Wu H, Song Z, Hentzer M, et al. Synthetic furanones inhibit quorum-sensing and enhance bacterial clearance in Pseudomonas aeruginosa lung infection in mice.[J]. J Antimicrob Chemother.2004, 53(6):1054-1061.
[22]Hentzer M, Riedel K, Rasmussen T B, et al. Inhibition of quorum sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound.[J]. Microbiology.2002,148(Pt 1):87-102.
[23]Bosgelmez-Tinaz G, Ulusoy S. Characterization of N-butanoyl-L-homoserine lactone (C4-HSL) deficient clinical isolates of Pseudomonas aeruginosa. [J]. Microb Pathog.2008,44(1):13-19.
[24]Schuster M, Greenberg E P. A network of networks:quorum-sensing gene regulation in Pseudomonas aeruginosa.[J]. Int J Med Microbiol.2006,296(2-3):73-81.
[25]Bratu S, Gupta J, Quale J. Expression of the las and rhl quorum-sensing systems in clinical isolates of Pseudomonas aeruginosa does not correlate with efflux pump expression or antimicrobial resistance.[J]. J Antimicrob Chemother.2006,58(6):1250-1253.
[26]Kumari A, Pasini P, Daunert S. Detection of bacterial quorum sensing N-acyl homoserine lactones in clinical samples.[J]. Anal Bioanal Chem.2008,391(5):1619-1627.
[27]Schaber J A, Carty N L, Mcdonald N A, et al. Analysis of quorum sensing-deficient clinical isolates of Pseudomonas aeruginosa.[J]. J Med Microbiol.2004,53(Pt 9):841-853.
[1]Lyczak J B, Cannon C L, Pier G B. Establishment of Pseudomonas aeruginosa infection:lessons from a versatile opportunist.[J]. Microbes Infect.2000,2(9):1051-1060.
[2]汪复.2006年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志.2008，8(1):1-9.
[3]Dunn M, Wunderink R G. Ventilator-associated pneumonia caused by Pseudomonas infection.[J]. Clin Chest Med.1995,16(1):95-109.
[4]Hirakata Y, Srikumar R, Poole K, et al. Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa.[J]. J Exp Med.2002,196(1):109-118.
[5]Costerton J W, Stewart P S, Greenberg E P. Bacterial biofilms:a common cause of persistent infections.[J]. Science.1999,284(5418):1318-1322.
[6]Rasmussen T B, Givskov M. Quorum-sensing inhibitors as anti-pathogenic drugs.[J]. Int J Med Microbiol.2006,296(2-3):149-161.
[7]Whitehead N A, Barnard A M, Slater H, et al. Quorum-sensing in Gram-negative bacteria.[J]. FEMS Microbiol Rev.2001,25(4):365-404.
[8]Miller M B, Bassler B L. Quorum sensing in bacteria.[J]. Annu Rev Microbiol.2001,55:165-199.
[9]Smith R S, Iglewski B H. P. aeruginosa quorum-sensing systems and virulence.[J]. Curr Opin Microbiol.2003,6(1):56-60.
[10]Heurlier K, Denervaud V, Haas D. Impact of quorum sensing on fitness of Pseudomonas aeruginosa.[J]. Int J Med Microbiol.2006,296(2-3):93-102.
[11]Venturi V. Regulation of quorum sensing in Pseudomonas.[J]. FEMS Microbiol Rev.2006,30(2): 274-291.
[12]Pesci E C, Pearson J P, Seed P C, et al. Regulation of las and rhl quorum sensing in Pseudomonas aeruginosa.[J]. J Bacteriol.1997,179(10):3127-3132.
[13]Fuqua W C, Winans S C, Greenberg E P. Quorum sensing in bacteria:the LuxR-LuxI family of cell density-responsive transcriptional regulators.[J]. J Bacteriol.1994,176(2):269-275.
[14]De Kievit T R, Iglewski B H. Bacterial quorum sensing in pathogenic relationships.[J]. Infect
Immun.2000,68(9):4839-4849.
[15]Reading N C, Sperandio V. Quorum sensing:the many languages of bacteria.[J]. FEMS Microbiol Lett.2006,254(1):1-11.
[16]Juhas M, Eberl L, Tummler B. Quorum sensing:the power of cooperation in the world of Pseudomonas.[J]. Environ Microbiol.2005,7(4):459-471.
[17]Parsek M R, Greenberg E P. Sociomicrobiology:the connections between quorum sensing and biofilms.[J]. Trends Microbiol.2005,13(1):27-33.
[18]Shiner E K, Rumbaugh K P, Williams S C. Inter-kingdom signaling:deciphering the language of acyl homoserine lactones.[J]. FEMS Microbiol Rev.2005,29(5):935-947.
[19]Rumbaugh K P, Diggle S P, Watters C M, et al. Quorum sensing and the social evolution of bacterial virulence.[J]. Curr Biol.2009,19(4):341-345.
[20]Williams P. Quorum sensing, communication and cross-kingdom signalling in the bacterial world.[J]. Microbiology.2007,153(Pt 12):3923-3938.
[21]Willcox M D, Zhu H, Conibear T C, et al. Role of quorum sensing by Pseudomonas aeruginosa in microbial keratitis and cystic fibrosis.[J]. Microbiology.2008,154(Pt 8):2184-2194.
[22]Pearson J P, Gray K M, Passador L, et al. Structure of the autoinducer required for expression of Pseudomonas aeruginosa virulence genes.[J]. Proc Natl Acad Sci U S A.1994,91(1):197-201.
[23]Wagner V E, Frelinger J G, Barth R K, et al. Quorum sensing:dynamic response of Pseudomonas aeruginosa to external signals.[J]. Trends Microbiol.2006,14(2):55-58.
[24]Van Delden C, Iglewski B H. Cell-to-cell signaling and Pseudomonas aeruginosa infections.[J]. Emerg Infect Dis.1998,4(4):551-560.
[25]Pearson J P, Van Delden C, Iglewski B H. Active efflux and diffusion are involved in transport of Pseudomonas aeruginosa cell-to-cell signals.[J]. J Bacteriol.1999,181(4):1203-1210.
[26]Maseda H, Sawada I, Saito K, et al. Enhancement of the mexAB-oprM efflux pump expression by a quorum-sensing autoinducer and its cancellation by a regulator, MexT, of the mexEF-oprN efflux pump operon in Pseudomonas aeruginosa.[J]. Antimicrob Agents Chemother.2004,48(4): 1320-1328.
[27]Evans K, Passador L, Srikumar R, et al. Influence of the MexAB-OprM multidrug efflux system on quorum sensing in Pseudomonas aeruginosa.[J]. J Bacteriol.1998,180(20):5443-5447.
[28]Fuqua C. The QscR quorum-sensing regulon of Pseudomonas aeruginosa:an orphan claims its identity.[J]. J Bacteriol.2006,188(9):3169-3171.
[29]Lequette Y, Lee J H, Ledgham F, et al. A distinct QscR regulon in the Pseudomonas aeruginosa quorum-sensing circuit.[J]. J Bacteriol.2006,188(9):3365-3370.
[30]Lee J H, Lequette Y, Greenberg E P. Activity of purified QscR, a Pseudomonas aeruginosa orphan quorum-sensing transcription factor.[J]. Mol Microbiol.2006,59(2):602-609.
[31]王沂，严安，黄显清，等.假单胞菌M-18qscR突变株的构建及其对抗生素合成的调控[J].微生物学报.2007，47(2):254-259.
[32]Davies D G, Parsek M R, Pearson J P, et al. The involvement of cell-to-cell signals in the development of a bacterial biofilm.[J]. Science.1998,280(5361):295-298.
[33]Pearson J P, Feldman M, Iglewski B H, et al. Pseudomonas aeruginosa cell-to-cell signaling is required for virulence in a model of acute pulmonary infection.[J]. Infect Immun.2000,68(7): 4331-4334.
[34]Bosgelmez-Tinaz G, Ulusoy S. Characterization of N-butanoyl-L-homoserine lactone (C4-HSL) deficient clinical isolates of Pseudomonas aeruginosa.[J]. Microb Pathog.2008,44(1):13-19.
[35]Borriello G, Werner E, Roe F, et al. Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms.[J]. Antimicrob Agents Chemother.2004,48(7):2659-2664.
[36]Glessner A, Smith R S, Iglewski B H, et al. Roles of Pseudomonas aeruginosa las and rhl quorum-sensing systems in control of twitching motility.[J]. J Bacteriol.1999,181(5): 1623-1629.
[37]Smith R S, Iglewski B H. Pseudomonas aeruginosa quorum sensing as a potential antimicrobial target.[J]. J Clin Invest.2003,112(10):1460-1465.
[38]Passador L, Cook J M, Gambello M J, et al. Expression of Pseudomonas aeruginosa virulence genes requires cell-to-cell communication.[J]. Science.1993,260(5111):1127-1130.
[39]Hentzer M, Givskov M. Pharmacological inhibition of quorum sensing for the treatment of chronic
bacterial infections.[J]. J Clin Invest.2003,112(9):1300-1307.
[40]Hentzer M, Wu H, Andersen J B, et al. Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors.[J]. EMBO J.2003,22(15):3803-3815.
[41]Winstanley C, Fothergill J L. The role of quorum sensing in chronic cystic fibrosis Pseudomonas aeruginosa infections.[J]. FEMS Microbiol Lett.2009,290(1):1-9.
[42]Hughes D T, Sperandio V. Inter-kingdom signalling:communication between bacteria and their hosts.[J]. Nat Rev Microbiol.2008,6(2):111-120.
[43]Kendall M M, Sperandio V. Quorum sensing by enteric pathogens.[J]. Curr Opin Gastroenterol. 2007,23(1):10-15.
[44]Telford G, Wheeler D, Williams P, et al. The Pseudomonas aeruginosa quorum-sensing signal molecule N-(3-oxododecanoyl)-L-homoserine lactone has immunomodulatory activity.[J]. Infect Immun.1998,66(1):36-42.
[45]Saleh A, Figarella C, Kammouni W, et al. Pseudomonas aeruginosa quorum-sensing signal molecule N-(3-oxododecanoyl)-L-homoserine lactone inhibits expression of P2Y receptors in cystic fibrosis tracheal gland cells.[J]. Infect Immun.1999,67(10):5076-5082.
[46]Kaufmann G F, Sartorio R, Lee S H, et al. Revisiting quorum sensing:Discovery of additional chemical and biological functions for 3-oxo-N-acylhomoserine lactones.[J]. Proc Natl Acad Sci U S A.2005,102(2):309-314.
[47]Nadell C D, Xavier J B, Levin S A, et al. The evolution of quorum sensing in bacterial biofilms.[J], PLoS Biol.2008,6(1):14.
[48]Parsek M R, Tolker-Nielsen T. Pattern formation in Pseudomonas aeruginosa biofilms.[J]. Curr Opin Microbiol.2008,11(6):560-566.
[49]Wu H, Song Z, Givskov M, et al. Pseudomonas aeruginosa mutations in lasl and rhll quorum sensing systems result in milder chronic lung infection.[J]. Microbiology.2001,147(Pt 5): 1105-1113.
[50]Costerton J W. Anaerobic biofilm infections in cystic fibrosis.[J]. Mol Cell.2002,10(4):699-700.
[51]Hassett D J, Cuppoletti J, Trapnell B, et al. Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways:rethinking antibiotic treatment strategies and drug targets.[J]. Adv Drug Deliv Rev.2002,54(11):1425-1443.
[52]Rumbaugh K P. Convergence of hormones and autoinducers at the host/pathogen interface. [J]. Anal Bioanal Chem.2007,387(2):425-435.
[53]Chhabra S R, Harty C, Hooi D S, et al. Synthetic analogues of the bacterial signal (quorum sensing) molecule N-(3-oxododecanoyl)-L-homoserine lactone as immune modulators.[J]. J Med Chem. 2003,46(1):97-104.
[54]Rodriguez-Martinez J M, Pascual A. [Activity of antimicrobial agents on bacterial biofilms][J]. Enferm Infecc Microbiol Clin.2008,26(2):107-114.
[55]Spormann A M. Physiology of microbes in biofilms.[J]. Curr Top Microbiol Immunol.2008,322: 17-36.
[56]Wagner V E, Iglewski B H. P. aeruginosa Biofilms in CF Infection.[J]. Clin Rev Allergy Immunol. 2008,35(3):124-134.
[57]Nickel J C, Ruseska I, Wright J B, et al. Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material.[J]. Antimicrob Agents Chemother.1985,27(4): 619-624.
[58]Schweizer H P. Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria:unanswered questions.[J]. Genet Mol Res.2003,2(1):48-62.
[59]Poole K. Efflux-mediated multiresistance in Gram-negative bacteria.[J]. Clin Microbiol Infect.2004, 10(1):12-26.
[60]Hancock R E, Brinkman F S. Function of pseudomonas porins in uptake and efflux.[J]. Annu Rev Microbiol.2002,56:17-38.
[61]Webber M A, Piddock L J. The importance of efflux pumps in bacterial antibiotic resistance.[J]. J Antimicrob Chemother.2003,51(1):9-11.
[62]Poole K. Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms.[J]. J Mol Microbiol Biotechnol.2001,3(2):255-264.
[63]Poole K, Krebes K, Mcnally C, et al. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon.[J]. J Bacteriol.1993,175(22):7363-7372.
[64]Poole K, Srikumar R. Multidrug efflux in Pseudomonas aeruginosa:components, mechanisms and clinical significance.[J]. Curr Top Med Chem.2001,1(1):59-71.
[65]Saito K, Eda S, Maseda H, et al. Molecular mechanism of MexR-mediated regulation of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa.[J]. FEMS Microbiol Lett. 2001,195(1):23-28.
[66]Dockery J D, Keener J P. A mathematical model for quorum sensing in Pseudomonas aeruginosa.[J]. Bull Math Biol.2001,63(1):95-116.
[67]Douglas M W, Mulholland K, Denyer V, et al. Multi-drug resistant Pseudomonas aeruginosa outbreak in a burns unit-an infection control study.[J]. Burns.2001,27(2):131-135.
[68]Fagerlind M G, Rice S A, Nilsson P, et al. The role of regulators in the expression of quorum-sensing signals in Pseudomonas aeruginosa.[J]. J Mol Microbiol Biotechnol.2003,6(2): 88-100.
[69]Fang X Q, Wang W F, Liu Y N. [The role of the quorum sensing system in a rat model of Pseudomonas aeruginosa pulmonary infection and its relationship with the expression of virulence factors][J]. Zhonghua Jie He He Hu Xi Za Zhi.2006,29(7):458-462.
[70]Huang C T, Shih P C. Effects of quorum sensing signal molecules on the hydrogen peroxide resistance against planktonic Pseudomonas aeruginosa.[J]. J Microbiol Immunol Infect.2000,33(3): 154-158.
[71]Imamura Y, Yanagihara K, Tomono K, et al. Role of Pseudomonas aeruginosa quorum-sensing systems in a mouse model of chronic respiratory infection.[J]. J Med Microbiol.2005,54(Pt 6): 515-518.
[72]Ishida T, Ikeda T, Takiguchi N, et al. Inhibition of quorum sensing in Pseudomonas aeruginosa by N-acyl cyclopentylamides.[J]. Appl Environ Microbiol.2007,73(10):3183-3188.
[73]Nakae T, Tanaka J, Nakano A, et al. Complement-mediated bactericidal effect of antibodies in human intravenous preparation against multi-drug resistant pseudomonas aeruginosa.[J]. Jpn J Antibiot.2008,61(6):379-387.
[74]Manefield M, Rasmussen T B, Henzter M, et al. Halogenated furanones inhibit quorum sensing through accelerated LuxR turnover.[J]. Microbiology.2002,148(Pt 4):1119-1127.
[75]Daniels R, Vanderleyden J, Michiels J. Quorum sensing and swarming migration in bacteria. [J]. FEMS Microbiol Rev.2004,28(3):261-289.
[76]Dong Y H, Wang L H, Xu J L, et al. Quenching quorum-sensing-dependent bacterial infection by an N-acyl homoserine lactonase. [J]. Nature.2001,411(6839):813-817.
[77]Dong Y H, Gusti A R, Zhang Q, et al. Identification of quorum-quenching N-acyl homoserine lactonases from Bacillus species.[J]. Appl Environ Microbiol.2002,68(4):1754-1759.
[78]Thomas P W, Stone E M, Costello A L, et al. The quorum-quenching lactonase from Bacillus thuringiensis is a metalloprotein.[J]. Biochemistry.2005,44(20):7559-7569.
[79]Zhao C, Zeng H, Yu Z, et al. N-Acyl homoserine lactonase promotes prevention of Erwinia virulence with zwittermicin A-producing strain Bacillus cereus.[J]. Biotechnol Bioeng.2008, 100(3):599-603.
[80]Pan J, Huang T, Yao F, et al. Expression and characterization of aiiA gene from Bacillus subtilis BS-1.[J]. Microbiol Res.2008,163(6):711-716.
[81]Hoang T T, Sullivan S A, Cusick J K, et al. Beta-ketoacyl acyl carrier protein reductase (FabG) activity of the fatty acid biosynthetic pathway is a determining factor of 3-oxo-homoserine lactone acyl chain lengths.[J]. Microbiology.2002,148(Pt 12):3849-3856.
[82]Fulghesu L, Giallorenzo C, Savoia D. Evaluation of different compounds as quorum sensing inhibitors in Pseudomonas aeruginosa.[J]. J Chemother.2007,19(4):388-391.
[2]刘振声；金大棚；陈增辉．医院感染管理学[G]．北京：军事医学科学出版社，2000．
[3]Stover C K, Pham X Q, Erwin A L, et al. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen.[J]. Nature.2000,406(6799):959-964.
[4]Lyczak J B, Cannon C L, Pier G B. Establishment of Pseudomonas aeruginosa infection:lessons from a versatile opportunist.[J]. Microbes Infect.2000,2(9):1051-1060.
[5]Pier G. Pseudomonas aeruginosa:a key problem in cystic fibrosis[J]. ASM News.1998,64(6): 339-347.
[6]谢丽丽，熊盛道，刘谨，等．铜绿假单胞菌耐亚胺培南相关基因OprD2研究[J]．医药导报．2006，25(2)：102-104．
[7]陈民钧，王辉，中国医院内病原菌耐药监测网．中国重症监护病房革兰阴性菌耐药性连续7年监测研究[J]．中华医学杂志．2003，83(5)．
[8]曹彬，王辉，朱元珏，等．多药耐药铜绿假单胞菌院内感染危险因素及预后因素分析[J]．中华结核和呼吸杂志．2004，27(1)．
[9]叶惠芬，杨银梅，陈惠玲，等．2001年广州地区常见病原菌耐药性调查[J]．中国抗生素杂志．2002，27(10)．
[10]Cowell B A, Chen D Y, Frank D W, et al. ExoT of cytotoxic Pseudomonas aeruginosa prevents uptake by corneal epithelial cells.[J]. Infect Immun.2000,68(1):403-406.
[11]Murray S A, Snydman D R. Investigation of an epidemic of multi-drug resistant Pseudomonas aeruginosa.[J]. Infect Control.1982,3(6):456-460.
[12]Nakayama I, Yamaji E. [The recent trend of multi-drug resistant Pseudomonas aeruginosa in the field of surgery][J]. Nippon Rinsho.1991,49(10):2373-2380.
[13]Tomono K, Sawai T, Kohno S. [Multi-drug resistant Pseudomonas aeruginosa infection][J]. Ryoikibetsu Shokogun Shirizu.1999(23 Pt 1):198-201.
[14]Tomasoni D, Gattuso G, Chiarelli C, et al. [Epidemiologic surveillance of multi-drug resistant Pseudomonas aeruginosa in Mantova Hospital (Italy)][J]. Infez Med.2006,14(2):85-91.
[15]Anguige K, King J R, Ward J P. Modelling antibiotic-and anti-quorum sensing treatment of a spatially-structured Pseudomonas aeruginosa population.[J]. J Math Biol.2005,51(5):557-594.
[16]Bjarnsholt T, Jensen P O, Burmolle M, et al. Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent.[J]. Microbiology.2005,151(Pt2):373-383.
[17]Cao B, Wang H, Sun H, et al. Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections.[J]. J Hosp Infect.2004,57(2):112-118.
[18]Chapon-Herve V, Akrim M, Latifi A, et al. Regulation of the xcp secretion pathway by multiple quorum-sensing modulons in Pseudomonas aeruginosa.[J]. Mol Microbiol.1997,24(6):1169-1178.
[19]Chernukha M, Shaginian I A, Romanova I, et al. [The role of "quorum sensing" regulation system in symbiotic interaction of bacteria Burkholderia cepacia and Pseudomonas aeruginosa during mixed infection][J]. Zh Mikrobiol Epidemiol Immunobiol.2006(4):32-37.
[20]Falagas M E, Kopterides P. Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa:a systematic review of the literature.[J]. J Hosp Infect. 2006,64(1):7-15.
[21]Hasegawa M, Kobayashi I, Saika T, et al. [Development of multi-drug resistant mutants of clinical isolates of Pseudomonas aeruginosa after exposure to fluoroquinolone][J]. Kansenshogaku Zasshi. 1996,70(2):123-131.
[22]Hust'Avova H, Krcmery V, Kanik K, et al. Conjugation in lysogenic, multiple-drug resistant, nosocomial strains of Pseudomonas aeruginosa producing a hemolytic toxin.[J]. Zentralbl Bakteriol Orig A.1977,239(1):59-61.
[23]Girard G, Bloemberg G V. Central role of quorum sensing in regulating the production of pathogenicity factors in Pseudomonas aeruginosa.[J]. Future Microbiol.2008,3(1):97-106.
[24]Jayakumar S, Appalaraju B. Prevalence of multi and pan drug resistant Pseudomonas aeruginosa with respect to ESBL and MBL in a tertiary care hospital.[J]. Indian J Pathol Microbiol.2007,
50(4):922-925.
[25]王辉，陈民钧，中国医院内病原菌耐药监测网．1994-2001年中国重症监护病房非发酵糖细菌的耐药变迁[J]．中华医学杂志．2003，83(5)．
[26]刘蓉，周黎明，王浴生．铜绿假单胞菌对β-内酰胺类抗生素耐药机制[J]．四川生理科学杂志．2004，26(4)．
[27]植志全，何志恒，江鹏，等．多重耐药绿脓假单胞菌β内酰胺类氨基糖苷类耐药相关基因研究[J]．中华检验医学杂志．2005，28(11)：1211-1214．
[28]张春平，龙腾镶，黄文方，等．铜绿假单胞菌产金属β-内酰胺酶的研究进展[J]．国际检验医学杂志．2006，27(3)：252-254．
[29]胡锡浩，许小敏，虞江声，等．耐亚胺培南铜绿假单胞菌产金属β-内酰胺酶的检测及其耐药性分析[J]．现代实用医学．2006，18(5)：306-308．
[30]王佩芬，张娟，黄源春．耐亚胺培南铜绿假单胞菌产金属β-内酰胺酶的研究[J]．国际检验医学杂志．2006，27(5)：405-406．
[31]Mugnier P, Dubrous P, Casin I, et al. A TEM-derived extended-spectrum beta-lactamase in Pseudomonas aeruginosa.[J]. Antimicrob Agents Chemother.1996,40(11):2488-2493.
[32]Lepper P M, Grusa E, Reichl H, et al. Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa.[J]. Antimicrob Agents Chemother.2002,46(9):2920-2925.
[33]陈瑞，唐英春，朱家馨，等．铜绿假单胞菌对碳青霉烯类抗生素的耐药机制——耐药株外膜蛋白OprD2缺失[J]．中国抗感染化疗杂志．2001，1(4)．
[34]蒋伟，常东，黄志红，等．多重耐药铜绿假单胞菌氨基糖苷类修饰酶基因及qacE △ 1基因检测研究[J]．解放军医学杂志．2006，3l(1)．
[35]Mouneimne H, Robert J, Jarlier V, et al. Type Ⅱ topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa.[J]. Antimicrob Agents Chemother.1999,43(1):62-66.
[36]Akasaka T, Tanaka M, Yamaguchi A, et al. Type Ⅱ topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance.[J]. Antimicrob Agents Chemother.2001,45(8):2263-2268.
[37]Brown M H, Paulsen I T, Skurray R A. The multidrug efflux protein NorM is a prototype of a new family of transporters. [J]. Mol Microbiol.1999,31(1):394-395.
[38]Nickel J C, Ruseska I, Wright J B, et al. Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material.[J]. Antimicrob Agents Chemother.1985,27(4): 619-624.
[39]Lawrence D. Clues to mechanism of Pseudomonas resistance in cystic fibrosis.[J]. Lancet.2002, 359(9315):1410.
[40]Patel R. Biofilms and antimicrobial resistance.[J]. Clin Orthop Relat Res.2005(437):41-47.
[41]Stewart P S, Costerton J W. Antibiotic resistance of bacteria in biofilms.[J]. Lancet.2001, 358(9276):135-138.
[42]Sedlacek M J, Walker C. Antibiotic resistance in an in vitro subgingival biofilm model.[J]. Oral Microbiol Immunol.2007,22(5):333-339.
[43]Lee H W, Koh Y M, Kim J, et al. Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces.[J]. Clin Microbiol Infect.2008, 14(1):49-54.
[44]张海平，胡必杰，李华茵，等.头孢他啶对早期和成熟期绿脓假单胞菌生物膜菌作用的差别[J].中华检验医学杂志.2003，26(6):349-351.
[45]孙景勇，倪语星.住院病人中分离的革兰阴性杆菌的分布与耐药特征[J].中国抗感染化疗杂志.2002，2(3).
[1]Smith K M, Bu Y, Suga H. Induction and inhibition of Pseudomonas aeruginosa quorum sensing by synthetic autoinducer analogs.[J]. Chem Biol.2003,10(1):81-89.
[2]Schaber J A, Carty N L, Mcdonald N A, et al. Analysis of quorum sensing-deficient clinical isolates of Pseudomonas aeruginosa.[J]. J Med Microbiol.2004,53(Pt 9):841-853.
[3]Essar D W, Eberly L, Hadero A, et al. Identification and characterization of genes for a second anthranilate synthase in Pseudomonas aeruginosa:interchangeability of the two anthranilate synthases and evolutionary implications.[J]. J Bacteriol.1990,172(2):884-900.
[4]Deziel E, Comeau Y, Villemur R. Initiation of biofilm formation by Pseudomonas aeruginosa 57RP correlates with emergence of hyperpiliated and highly adherent phenotypic variants deficient in swimming, swarming, and twitching motilities.[J]. J Bacteriol.2001,183(4):1195-1204.
[5]Bassetti M, Righi E, Viscoli C. Pseudomonas aeruginosa serious infections:mono or combination antimicrobial therapy?[J]. Curr Med Chem.2008,15(5):517-522.
[6]刘振声;金大棚;陈增辉.医院感染管理学[G].北京：军事医学科学出版社，2000.
[7]Davies D G, Parsek M R, Pearson J P, et al. The involvement of cell-to-cell signals in the development of a bacterial biofilm.[J]. Science.1998,280(5361):295-298.
[8]De Kievit T R, Iglewski B H. Bacterial quorum sensing in pathogenic relationships.[J]. Infect Immun.2000,68(9):4839-4849.
[9]Smith R S, Iglewski B H. P. aeruginosa quorum-sensing systems and virulence.[J]. Curr Opin Microbiol.2003,6(1):56-60.
[10]Cegelski L, Marshall G R, Eldridge G R, et al. The biology and future prospects of antivirulence therapies.[J]. Nat Rev Microbiol.2008,6(1):17-27.
[11]Rumbaugh K P, Diggle S P, Watters C M, et al. Quorum sensing and the social evolution of bacterial virulence.[J]. Curr Biol.2009,19(4):341-345.
[12]Sperandio V, Torres A G, Jarvis B, et al. Bacteria-host communication:the language of hormones.[J]. Proc Natl Acad Sci U S A.2003,100(15):8951-8956.
[13]Keller L, Surette M G. Communication in bacteria:an ecological and evolutionary perspective.[J]. Nat Rev Microbiol.2006,4(4):249-258.
[14]Rumbaugh K P. Convergence of hormones and autoinducers at the host/pathogen interface. [J]. Anal Bioanal Chem.2007,387(2):425-435.
[15]Shiner E K, Rumbaugh K P, Williams S C. Inter-kingdom signaling:deciphering the language of acyl homoserine lactones.[J]. FEMS Microbiol Rev.2005,29(5):935-947.
[16]Hughes D T, Sperandio V. Inter-kingdom signalling:communication between bacteria and their hosts.[J]. Nat Rev Microbiol.2008,6(2):111-120.
[17]Sperandio V. Striking a balance:inter-kingdom cell-to-cell signaling, friendship or war?[J]. Trends Immunol.2004,25(10):505-507.
[18]Bratu S, Gupta J, Quale J. Expression of the las and rhl quorum-sensing systems in clinical isolates of Pseudomonas aeruginosa does not correlate with efflux pump expression or antimicrobial resistance.[J]. J Antimicrob Chemother.2006,58(6):1250-1253.
[19]Kumari A, Pasini P, Daunert S. Detection of bacterial quorum sensing N-acyl homoserine lactones in clinical samples.[J]. Anal Bioanal Chem.2008,391(5):1619-1627.
[20]Schaber J A, Carty N L, Mcdonald N A, et al. Analysis of quorum sensing-deficient clinical isolates of Pseudomonas aeruginosa. [J]. J Med Microbiol.2004,53(Pt 9):841-853.
[21]Bosgelmez-Tinaz G, Ulusoy S. Characterization of N-butanoyl-L-homoserine lactone (C4-HSL) deficient clinical isolates of Pseudomonas aeruginosa. [J]. Microb Pathog.2008,44(1):13-19.
[22]Bever R A, Iglewski B H. Molecular characterization and nucleotide sequence of the Pseudomonas aeruginosa elastase structural gene.[J]. J Bacteriol.1988,170(9):4309-4314.
[23]Ball G, Durand E, Lazdunski A, et al. A novel type II secretion system in Pseudomonas aeruginosa.[J]. Mol Microbiol.2002,43(2):475-485.
[24]Mciver K S, Olson J C, Ohman D E. Pseudomonas aeruginosa lasB 1 mutants produce an elastase, substituted at active-site His-223, that is defective in activity, processing, and secretion.[J]. J Bacteriol.1993,175(13):4008-4015.
[25]Yanagihara K, Tomono K, Kaneko Y, et al. Role of elastase in a mouse model of chronic
respiratory Pseudomonas aeruginosa infection that mimics diffuse panbronchiolitis.[J]. J Med Microbiol.2003,52(Pt 6):531-535.
[26]Heck L W, Morihara K, Mcrae W B, et al. Specific cleavage of human type Ⅲ and Ⅳ collagens by Pseudomonas aeruginosa elastase.[J]. Infect Immun.1986,51(1):115-118.
[27]Heck L W, Alarcon P G, Kulhavy R M, et al. Degradation of IgA proteins by Pseudomonas aeruginosa elastase.[J]. J Immunol.1990,144(6):2253-2257.
[28]Schmidtchen A, Holst E, Tapper H, et al. Elastase-producing Pseudomonas aeruginosa degrade plasma proteins and extracellular products of human skin and fibroblasts, and inhibit fibroblast growth.[J]. Microb Pathog.2003,34(1):47-55.
[29]Hamdaoui A, Wund-Bisseret F, Bieth J G. Fast solubilization of human lung elastin by Pseudomonas aeruginosa elastase.[J]. Am Rev Respir Dis.1987,135(4):860-863.
[30]Reimer A, Edvaller B, Johansson B. Concentrations of the Pseudomonas aeruginosa toxin pyocyanin in human ear secretions.[J]. Acta Otolaryngol Suppl.2000,543:86-88.
[31]Nadell C D, Xavier J B, Levin S A, et al. The evolution of quorum sensing in bacterial biofilms.[J]. PLoS Biol.2008,6(1):14.
[32]Parsek M R, Tolker-Nielsen T. Pattern formation in Pseudomonas aeruginosa biofilms.[J]. Curr Opin Microbiol.2008,11(6):560-566.
[33]Rodriguez-Martinez J M, Pascual A. [Activity of antimicrobial agents on bacterial biofilms][J]. Enferm Infecc Microbiol Clin.2008,26(2):107-114.
[34]Spormann A M. Physiology of microbes in biofilms.[J]. Curr Top Microbiol Immunol.2008,322: 17-36.
[35]Wagner V E, Iglewski B H. P. aeruginosa Biofilms in CF Infection.[J]. Clin Rev Allergy Immunol. 2008,35(3):124-134.
[36]Lee H W, Koh Y M, Kim J, et al. Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces.[J]. Clin Microbiol Infect.2008, 14(1):49-54.
[37]Sedlacek M J, Walker C. Antibiotic resistance in an in vitro subgingival biofilm model.[J]. Oral Microbiol Immunol.2007,22(5):333-339.
[38]Stewart P S, Costerton J W. Antibiotic resistance of bacteria in biofilms.[J]. Lancet.2001, 358(9276):135-138.
[39]Patel R. Biofilms and antimicrobial resistance.[J]. Clin Orthop Relat Res.2005(437):41-47.
[40]Lawrence D. Clues to mechanism of Pseudomonas resistance in cystic fibrosis.[J]. Lancet.2002, 359(9315):1410.
[1]Schaber J A, Carty N L, Mcdonald N A, et al. Analysis of quorum sensing-deficient clinical isolates of Pseudomonas aeruginosa.[J]. J Med Microbiol.2004,53(Pt 9):841-853.
[2]Smith R S, Iglewski B H. P. aeruginosa quorum-sensing systems and virulence.[J]. Curr Opin Microbiol.2003,6(1):56-60.
[3]Borriello G, Werner E, Roe F, et al. Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms.[J]. Antimicrob Agents Chemother.2004,48(7):2659-2664.
[4]Pearson J P, Feldman M, Iglewski B H, et al. Pseudomonas aeruginosa cell-to-cell signaling is required for virulence in a model of acute pulmonary infection.[J]. Infect Immun.2000,68(7): 4331-4334.
[5]De Kievit T R, Iglewski B H. Bacterial quorum sensing in pathogenic relationships.[J]. Infect Immun.2000,68(9):4839-4849.
[6]Bosgelmez-Tinaz G, Ulusoy S. Characterization of N-butanoyl-L-homoserine lactone (C4-HSL) deficient clinical isolates of Pseudomonas aeruginosa.[J]. Microb Pathog.2008,44(1):13-19.
[7]Lawrence D. Clues to mechanism of Pseudomonas resistance in cystic fibrosis.[J]. Lancet.2002, 359(9315):1410.
[8]Lee H W, Koh Y M, Kim J, et al. Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces.[J]. Clin Microbiol Infect.2008, 14(1):49-54.
[9]Patel R. Biofilms and antimicrobial resistance.[J]. Clin Orthop Relat Res.2005(437):41-47.
[10]Sedlacek M J, Walker C. Antibiotic resistance in an in vitro subgingival biofilm model.[J]. Oral Microbiol Immunol.2007,22(5):333-339.
[11]Stewart P S, Costerton J W. Antibiotic resistance of bacteria in biofilms.[J]. Lancet.2001, 358(9276):135-138.
[12]Borriello G, Werner E, Roe F, et al. Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms.[J]. Antimicrob Agents Chemother.2004,48(7):2659-2664.
[13]Smith R S, Iglewski B H. Pseudomonas aeruginosa quorum sensing as a potential antimicrobial target.[J]. J Clin Invest.2003,112(10):1460-1465.
[14]Rasmussen T B, Givskov M. Quorum-sensing inhibitors as anti-pathogenic drugs.[J]. Int J Med Microbiol.2006,296(2-3):149-161.
[15]Wagner V E, Bushnell D, Passador L, et al. Microarray analysis of Pseudomonas aeruginosa quorum-sensing regulons:effects of growth phase and environment.[J]. J Bacteriol.2003,185(7): 2080-2095.
[16]Schuster M, Lostroh C P, Ogi T, et al. Identification, timing, and signal specificity of Pseudomonas aeruginosa quorum-controlled genes:a transcriptome analysis.[J]. J Bacteriol.2003,185(7): 2066-2079.
[17]Hentzer M, Wu H, Andersen J B, et al. Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors.[J]. EMBO J.2003,22(15):3803-3815.
[18]Smith R S, Iglewski B H. P. aeruginosa quorum-sensing systems and virulence.[J]. Curr Opin Microbiol.2003,6(1):56-60.
[19]Willcox M D, Zhu H, Conibear T C, et al. Role of quorum sensing by Pseudomonas aeruginosa in microbial keratitis and cystic fibrosis.[J]. Microbiology.2008,154(Pt 8):2184-2194.
[20]Pearson J P, Pesci E C, Iglewski B H. Roles of Pseudomonas aeruginosa las and rhl quorum-sensing systems in control of elastase and rhamnolipid biosynthesis genes.[J]. J Bacteriol.1997,179(18): 5756-5767.
[21]Wu H, Song Z, Hentzer M, et al. Synthetic furanones inhibit quorum-sensing and enhance bacterial clearance in Pseudomonas aeruginosa lung infection in mice.[J]. J Antimicrob Chemother.2004, 53(6):1054-1061.
[22]Hentzer M, Riedel K, Rasmussen T B, et al. Inhibition of quorum sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound.[J]. Microbiology.2002,148(Pt 1):87-102.
[23]Bosgelmez-Tinaz G, Ulusoy S. Characterization of N-butanoyl-L-homoserine lactone (C4-HSL) deficient clinical isolates of Pseudomonas aeruginosa. [J]. Microb Pathog.2008,44(1):13-19.
[24]Schuster M, Greenberg E P. A network of networks:quorum-sensing gene regulation in Pseudomonas aeruginosa.[J]. Int J Med Microbiol.2006,296(2-3):73-81.
[25]Bratu S, Gupta J, Quale J. Expression of the las and rhl quorum-sensing systems in clinical isolates of Pseudomonas aeruginosa does not correlate with efflux pump expression or antimicrobial resistance.[J]. J Antimicrob Chemother.2006,58(6):1250-1253.
[26]Kumari A, Pasini P, Daunert S. Detection of bacterial quorum sensing N-acyl homoserine lactones in clinical samples.[J]. Anal Bioanal Chem.2008,391(5):1619-1627.
[27]Schaber J A, Carty N L, Mcdonald N A, et al. Analysis of quorum sensing-deficient clinical isolates of Pseudomonas aeruginosa.[J]. J Med Microbiol.2004,53(Pt 9):841-853.
[1]Lyczak J B, Cannon C L, Pier G B. Establishment of Pseudomonas aeruginosa infection:lessons from a versatile opportunist.[J]. Microbes Infect.2000,2(9):1051-1060.
[2]汪复.2006年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志.2008，8(1):1-9.
[3]Dunn M, Wunderink R G. Ventilator-associated pneumonia caused by Pseudomonas infection.[J]. Clin Chest Med.1995,16(1):95-109.
[4]Hirakata Y, Srikumar R, Poole K, et al. Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa.[J]. J Exp Med.2002,196(1):109-118.
[5]Costerton J W, Stewart P S, Greenberg E P. Bacterial biofilms:a common cause of persistent infections.[J]. Science.1999,284(5418):1318-1322.
[6]Rasmussen T B, Givskov M. Quorum-sensing inhibitors as anti-pathogenic drugs.[J]. Int J Med Microbiol.2006,296(2-3):149-161.
[7]Whitehead N A, Barnard A M, Slater H, et al. Quorum-sensing in Gram-negative bacteria.[J]. FEMS Microbiol Rev.2001,25(4):365-404.
[8]Miller M B, Bassler B L. Quorum sensing in bacteria.[J]. Annu Rev Microbiol.2001,55:165-199.
[9]Smith R S, Iglewski B H. P. aeruginosa quorum-sensing systems and virulence.[J]. Curr Opin Microbiol.2003,6(1):56-60.
[10]Heurlier K, Denervaud V, Haas D. Impact of quorum sensing on fitness of Pseudomonas aeruginosa.[J]. Int J Med Microbiol.2006,296(2-3):93-102.
[11]Venturi V. Regulation of quorum sensing in Pseudomonas.[J]. FEMS Microbiol Rev.2006,30(2): 274-291.
[12]Pesci E C, Pearson J P, Seed P C, et al. Regulation of las and rhl quorum sensing in Pseudomonas aeruginosa.[J]. J Bacteriol.1997,179(10):3127-3132.
[13]Fuqua W C, Winans S C, Greenberg E P. Quorum sensing in bacteria:the LuxR-LuxI family of cell density-responsive transcriptional regulators.[J]. J Bacteriol.1994,176(2):269-275.
[14]De Kievit T R, Iglewski B H. Bacterial quorum sensing in pathogenic relationships.[J]. Infect
Immun.2000,68(9):4839-4849.
[15]Reading N C, Sperandio V. Quorum sensing:the many languages of bacteria.[J]. FEMS Microbiol Lett.2006,254(1):1-11.
[16]Juhas M, Eberl L, Tummler B. Quorum sensing:the power of cooperation in the world of Pseudomonas.[J]. Environ Microbiol.2005,7(4):459-471.
[17]Parsek M R, Greenberg E P. Sociomicrobiology:the connections between quorum sensing and biofilms.[J]. Trends Microbiol.2005,13(1):27-33.
[18]Shiner E K, Rumbaugh K P, Williams S C. Inter-kingdom signaling:deciphering the language of acyl homoserine lactones.[J]. FEMS Microbiol Rev.2005,29(5):935-947.
[19]Rumbaugh K P, Diggle S P, Watters C M, et al. Quorum sensing and the social evolution of bacterial virulence.[J]. Curr Biol.2009,19(4):341-345.
[20]Williams P. Quorum sensing, communication and cross-kingdom signalling in the bacterial world.[J]. Microbiology.2007,153(Pt 12):3923-3938.
[21]Willcox M D, Zhu H, Conibear T C, et al. Role of quorum sensing by Pseudomonas aeruginosa in microbial keratitis and cystic fibrosis.[J]. Microbiology.2008,154(Pt 8):2184-2194.
[22]Pearson J P, Gray K M, Passador L, et al. Structure of the autoinducer required for expression of Pseudomonas aeruginosa virulence genes.[J]. Proc Natl Acad Sci U S A.1994,91(1):197-201.
[23]Wagner V E, Frelinger J G, Barth R K, et al. Quorum sensing:dynamic response of Pseudomonas aeruginosa to external signals.[J]. Trends Microbiol.2006,14(2):55-58.
[24]Van Delden C, Iglewski B H. Cell-to-cell signaling and Pseudomonas aeruginosa infections.[J]. Emerg Infect Dis.1998,4(4):551-560.
[25]Pearson J P, Van Delden C, Iglewski B H. Active efflux and diffusion are involved in transport of Pseudomonas aeruginosa cell-to-cell signals.[J]. J Bacteriol.1999,181(4):1203-1210.
[26]Maseda H, Sawada I, Saito K, et al. Enhancement of the mexAB-oprM efflux pump expression by a quorum-sensing autoinducer and its cancellation by a regulator, MexT, of the mexEF-oprN efflux pump operon in Pseudomonas aeruginosa.[J]. Antimicrob Agents Chemother.2004,48(4): 1320-1328.
[27]Evans K, Passador L, Srikumar R, et al. Influence of the MexAB-OprM multidrug efflux system on quorum sensing in Pseudomonas aeruginosa.[J]. J Bacteriol.1998,180(20):5443-5447.
[28]Fuqua C. The QscR quorum-sensing regulon of Pseudomonas aeruginosa:an orphan claims its identity.[J]. J Bacteriol.2006,188(9):3169-3171.
[29]Lequette Y, Lee J H, Ledgham F, et al. A distinct QscR regulon in the Pseudomonas aeruginosa quorum-sensing circuit.[J]. J Bacteriol.2006,188(9):3365-3370.
[30]Lee J H, Lequette Y, Greenberg E P. Activity of purified QscR, a Pseudomonas aeruginosa orphan quorum-sensing transcription factor.[J]. Mol Microbiol.2006,59(2):602-609.
[31]王沂，严安，黄显清，等.假单胞菌M-18qscR突变株的构建及其对抗生素合成的调控[J].微生物学报.2007，47(2):254-259.
[32]Davies D G, Parsek M R, Pearson J P, et al. The involvement of cell-to-cell signals in the development of a bacterial biofilm.[J]. Science.1998,280(5361):295-298.
[33]Pearson J P, Feldman M, Iglewski B H, et al. Pseudomonas aeruginosa cell-to-cell signaling is required for virulence in a model of acute pulmonary infection.[J]. Infect Immun.2000,68(7): 4331-4334.
[34]Bosgelmez-Tinaz G, Ulusoy S. Characterization of N-butanoyl-L-homoserine lactone (C4-HSL) deficient clinical isolates of Pseudomonas aeruginosa.[J]. Microb Pathog.2008,44(1):13-19.
[35]Borriello G, Werner E, Roe F, et al. Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms.[J]. Antimicrob Agents Chemother.2004,48(7):2659-2664.
[36]Glessner A, Smith R S, Iglewski B H, et al. Roles of Pseudomonas aeruginosa las and rhl quorum-sensing systems in control of twitching motility.[J]. J Bacteriol.1999,181(5): 1623-1629.
[37]Smith R S, Iglewski B H. Pseudomonas aeruginosa quorum sensing as a potential antimicrobial target.[J]. J Clin Invest.2003,112(10):1460-1465.
[38]Passador L, Cook J M, Gambello M J, et al. Expression of Pseudomonas aeruginosa virulence genes requires cell-to-cell communication.[J]. Science.1993,260(5111):1127-1130.
[39]Hentzer M, Givskov M. Pharmacological inhibition of quorum sensing for the treatment of chronic
bacterial infections.[J]. J Clin Invest.2003,112(9):1300-1307.
[40]Hentzer M, Wu H, Andersen J B, et al. Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors.[J]. EMBO J.2003,22(15):3803-3815.
[41]Winstanley C, Fothergill J L. The role of quorum sensing in chronic cystic fibrosis Pseudomonas aeruginosa infections.[J]. FEMS Microbiol Lett.2009,290(1):1-9.
[42]Hughes D T, Sperandio V. Inter-kingdom signalling:communication between bacteria and their hosts.[J]. Nat Rev Microbiol.2008,6(2):111-120.
[43]Kendall M M, Sperandio V. Quorum sensing by enteric pathogens.[J]. Curr Opin Gastroenterol. 2007,23(1):10-15.
[44]Telford G, Wheeler D, Williams P, et al. The Pseudomonas aeruginosa quorum-sensing signal molecule N-(3-oxododecanoyl)-L-homoserine lactone has immunomodulatory activity.[J]. Infect Immun.1998,66(1):36-42.
[45]Saleh A, Figarella C, Kammouni W, et al. Pseudomonas aeruginosa quorum-sensing signal molecule N-(3-oxododecanoyl)-L-homoserine lactone inhibits expression of P2Y receptors in cystic fibrosis tracheal gland cells.[J]. Infect Immun.1999,67(10):5076-5082.
[46]Kaufmann G F, Sartorio R, Lee S H, et al. Revisiting quorum sensing:Discovery of additional chemical and biological functions for 3-oxo-N-acylhomoserine lactones.[J]. Proc Natl Acad Sci U S A.2005,102(2):309-314.
[47]Nadell C D, Xavier J B, Levin S A, et al. The evolution of quorum sensing in bacterial biofilms.[J], PLoS Biol.2008,6(1):14.
[48]Parsek M R, Tolker-Nielsen T. Pattern formation in Pseudomonas aeruginosa biofilms.[J]. Curr Opin Microbiol.2008,11(6):560-566.
[49]Wu H, Song Z, Givskov M, et al. Pseudomonas aeruginosa mutations in lasl and rhll quorum sensing systems result in milder chronic lung infection.[J]. Microbiology.2001,147(Pt 5): 1105-1113.
[50]Costerton J W. Anaerobic biofilm infections in cystic fibrosis.[J]. Mol Cell.2002,10(4):699-700.
[51]Hassett D J, Cuppoletti J, Trapnell B, et al. Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways:rethinking antibiotic treatment strategies and drug targets.[J]. Adv Drug Deliv Rev.2002,54(11):1425-1443.
[52]Rumbaugh K P. Convergence of hormones and autoinducers at the host/pathogen interface. [J]. Anal Bioanal Chem.2007,387(2):425-435.
[53]Chhabra S R, Harty C, Hooi D S, et al. Synthetic analogues of the bacterial signal (quorum sensing) molecule N-(3-oxododecanoyl)-L-homoserine lactone as immune modulators.[J]. J Med Chem. 2003,46(1):97-104.
[54]Rodriguez-Martinez J M, Pascual A. [Activity of antimicrobial agents on bacterial biofilms][J]. Enferm Infecc Microbiol Clin.2008,26(2):107-114.
[55]Spormann A M. Physiology of microbes in biofilms.[J]. Curr Top Microbiol Immunol.2008,322: 17-36.
[56]Wagner V E, Iglewski B H. P. aeruginosa Biofilms in CF Infection.[J]. Clin Rev Allergy Immunol. 2008,35(3):124-134.
[57]Nickel J C, Ruseska I, Wright J B, et al. Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material.[J]. Antimicrob Agents Chemother.1985,27(4): 619-624.
[58]Schweizer H P. Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria:unanswered questions.[J]. Genet Mol Res.2003,2(1):48-62.
[59]Poole K. Efflux-mediated multiresistance in Gram-negative bacteria.[J]. Clin Microbiol Infect.2004, 10(1):12-26.
[60]Hancock R E, Brinkman F S. Function of pseudomonas porins in uptake and efflux.[J]. Annu Rev Microbiol.2002,56:17-38.
[61]Webber M A, Piddock L J. The importance of efflux pumps in bacterial antibiotic resistance.[J]. J Antimicrob Chemother.2003,51(1):9-11.
[62]Poole K. Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms.[J]. J Mol Microbiol Biotechnol.2001,3(2):255-264.
[63]Poole K, Krebes K, Mcnally C, et al. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon.[J]. J Bacteriol.1993,175(22):7363-7372.
[64]Poole K, Srikumar R. Multidrug efflux in Pseudomonas aeruginosa:components, mechanisms and clinical significance.[J]. Curr Top Med Chem.2001,1(1):59-71.
[65]Saito K, Eda S, Maseda H, et al. Molecular mechanism of MexR-mediated regulation of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa.[J]. FEMS Microbiol Lett. 2001,195(1):23-28.
[66]Dockery J D, Keener J P. A mathematical model for quorum sensing in Pseudomonas aeruginosa.[J]. Bull Math Biol.2001,63(1):95-116.
[67]Douglas M W, Mulholland K, Denyer V, et al. Multi-drug resistant Pseudomonas aeruginosa outbreak in a burns unit-an infection control study.[J]. Burns.2001,27(2):131-135.
[68]Fagerlind M G, Rice S A, Nilsson P, et al. The role of regulators in the expression of quorum-sensing signals in Pseudomonas aeruginosa.[J]. J Mol Microbiol Biotechnol.2003,6(2): 88-100.
[69]Fang X Q, Wang W F, Liu Y N. [The role of the quorum sensing system in a rat model of Pseudomonas aeruginosa pulmonary infection and its relationship with the expression of virulence factors][J]. Zhonghua Jie He He Hu Xi Za Zhi.2006,29(7):458-462.
[70]Huang C T, Shih P C. Effects of quorum sensing signal molecules on the hydrogen peroxide resistance against planktonic Pseudomonas aeruginosa.[J]. J Microbiol Immunol Infect.2000,33(3): 154-158.
[71]Imamura Y, Yanagihara K, Tomono K, et al. Role of Pseudomonas aeruginosa quorum-sensing systems in a mouse model of chronic respiratory infection.[J]. J Med Microbiol.2005,54(Pt 6): 515-518.
[72]Ishida T, Ikeda T, Takiguchi N, et al. Inhibition of quorum sensing in Pseudomonas aeruginosa by N-acyl cyclopentylamides.[J]. Appl Environ Microbiol.2007,73(10):3183-3188.
[73]Nakae T, Tanaka J, Nakano A, et al. Complement-mediated bactericidal effect of antibodies in human intravenous preparation against multi-drug resistant pseudomonas aeruginosa.[J]. Jpn J Antibiot.2008,61(6):379-387.
[74]Manefield M, Rasmussen T B, Henzter M, et al. Halogenated furanones inhibit quorum sensing through accelerated LuxR turnover.[J]. Microbiology.2002,148(Pt 4):1119-1127.
[75]Daniels R, Vanderleyden J, Michiels J. Quorum sensing and swarming migration in bacteria. [J]. FEMS Microbiol Rev.2004,28(3):261-289.
[76]Dong Y H, Wang L H, Xu J L, et al. Quenching quorum-sensing-dependent bacterial infection by an N-acyl homoserine lactonase. [J]. Nature.2001,411(6839):813-817.
[77]Dong Y H, Gusti A R, Zhang Q, et al. Identification of quorum-quenching N-acyl homoserine lactonases from Bacillus species.[J]. Appl Environ Microbiol.2002,68(4):1754-1759.
[78]Thomas P W, Stone E M, Costello A L, et al. The quorum-quenching lactonase from Bacillus thuringiensis is a metalloprotein.[J]. Biochemistry.2005,44(20):7559-7569.
[79]Zhao C, Zeng H, Yu Z, et al. N-Acyl homoserine lactonase promotes prevention of Erwinia virulence with zwittermicin A-producing strain Bacillus cereus.[J]. Biotechnol Bioeng.2008, 100(3):599-603.
[80]Pan J, Huang T, Yao F, et al. Expression and characterization of aiiA gene from Bacillus subtilis BS-1.[J]. Microbiol Res.2008,163(6):711-716.
[81]Hoang T T, Sullivan S A, Cusick J K, et al. Beta-ketoacyl acyl carrier protein reductase (FabG) activity of the fatty acid biosynthetic pathway is a determining factor of 3-oxo-homoserine lactone acyl chain lengths.[J]. Microbiology.2002,148(Pt 12):3849-3856.
[82]Fulghesu L, Giallorenzo C, Savoia D. Evaluation of different compounds as quorum sensing inhibitors in Pseudomonas aeruginosa.[J]. J Chemother.2007,19(4):388-391.